Binici, S. Et Al. 2024. Addressing radiotherapy-induced fibrosis: the potential of platelet-rich plasma and infliximab for improved breast cancer management. Histochemistry and Cell Biology , vol.161, no.5 , 381-389.

Binici, S., Güven, M., Özdemir, A., İlik, Z. A., Demirhan, B., Uygur, S., ... İliklerden, Ü. H.(2024). Addressing radiotherapy-induced fibrosis: the potential of platelet-rich plasma and infliximab for improved breast cancer management. Histochemistry and Cell Biology , vol.161, no.5, 381-389.

Binici, Serhat Et Al. "Addressing radiotherapy-induced fibrosis: the potential of platelet-rich plasma and infliximab for improved breast cancer management," Histochemistry and Cell Biology , vol.161, no.5, 381-389, 2024

Binici, Serhat Et Al. "Addressing radiotherapy-induced fibrosis: the potential of platelet-rich plasma and infliximab for improved breast cancer management." Histochemistry and Cell Biology , vol.161, no.5, pp.381-389, 2024

Binici, S. Et Al. (2024) . "Addressing radiotherapy-induced fibrosis: the potential of platelet-rich plasma and infliximab for improved breast cancer management." Histochemistry and Cell Biology , vol.161, no.5, pp.381-389.

@article{article, author={Serhat Binici Et Al. }, title={Addressing radiotherapy-induced fibrosis: the potential of platelet-rich plasma and infliximab for improved breast cancer management}, journal={Histochemistry and Cell Biology}, year=2024, pages={381-389} }